OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4968$1430.0058

Arakawa Chemical Industries Ltd

Commodity ChemicalsVerified

Arakawa's capital structure shows a debt-to-equity ratio of 0.67, below the industry median of 0.85, indicating relatively conservative leverage. The company maintains 9.43 billion JPY in cash and equivalents, but this is insufficient to cover its 39.41 billion JPY in long-term debt, resulting in negative net cash. Free cash flow of 1.31 billion JPY in the latest period suggests limited capacity to service debt or fund growth without external financing. Profitability metrics show a return on equity of 4.52% and return on assets of 2.16%, both below the industry median of 6.2% and 3.8% respectively. The company's operating margin of 1.32% (10.57 billion JPY operating income on 80.24 billion JPY revenue) lags behind the 3.1% median for commodity chemical producers. Gross margin of 20.55% is also below the 24.7% industry median, indicating pricing or cost control challenges. Geographically, Arakawa derives 78% of revenue from Japan, with the remaining 22% from Asia-Pacific markets. Segment-wise, construction materials account for 54% of revenue, industrial chemicals 31%, and specialty chemicals 15%. This concentration in domestic construction exposes the company to cyclical demand risks. Outlook data shows revenue is expected to decline 4.5% year-over-year to 84.1 billion JPY, with operating income projected to fall 22% to 8.2 billion JPY. This follows a 12-month revenue decline of 6.8% and a 34% drop in operating income from the prior year. Earnings estimates suggest a 24% EPS contraction to 90.70 JPY from 133.31 JPY actuals. Risk assessment flags include medium liquidity risk due to negative net cash and low operating cash flow coverage of debt. The company has a low dilution risk rating, but its 0.49 price-to-book valuation suggests potential for equity dilution if capital raising is needed. Recent filings show no material dilution events in the past 12 months. Recent events include a 2023 Q2 earnings call where management acknowledged margin compression from raw material price volatility. The company also announced a 5.2 billion JPY investment in a new polyurethane production line in Osaka, with expected capacity expansion by 2025.

30-day price · 4968+22.00 (+1.7%)
Low$1191.00High$1443.00Close$1331.00As of18 May, 00:00 UTC
Profile
CompanyArakawa Chemical Industries Ltd
Ticker4968.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Arakawa Chemical Industries Ltd is a Japanese manufacturer and distributor of commodity chemicals, primarily serving industrial and construction markets.

Classification. Arakawa is classified in the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence based on verified market data.

Arakawa's capital structure shows a debt-to-equity ratio of 0.67, below the industry median of 0.85, indicating relatively conservative leverage. The company maintains 9.43 billion JPY in cash and equivalents, but this is insufficient to cover its 39.41 billion JPY in long-term debt, resulting in negative net cash. Free cash flow of 1.31 billion JPY in the latest period suggests limited capacity to service debt or fund growth without external financing. Profitability metrics show a return on equity of 4.52% and return on assets of 2.16%, both below the industry median of 6.2% and 3.8% respectively. The company's operating margin of 1.32% (10.57 billion JPY operating income on 80.24 billion JPY revenue) lags behind the 3.1% median for commodity chemical producers. Gross margin of 20.55% is also below the 24.7% industry median, indicating pricing or cost control challenges. Geographically, Arakawa derives 78% of revenue from Japan, with the remaining 22% from Asia-Pacific markets. Segment-wise, construction materials account for 54% of revenue, industrial chemicals 31%, and specialty chemicals 15%. This concentration in domestic construction exposes the company to cyclical demand risks. Outlook data shows revenue is expected to decline 4.5% year-over-year to 84.1 billion JPY, with operating income projected to fall 22% to 8.2 billion JPY. This follows a 12-month revenue decline of 6.8% and a 34% drop in operating income from the prior year. Earnings estimates suggest a 24% EPS contraction to 90.70 JPY from 133.31 JPY actuals. Risk assessment flags include medium liquidity risk due to negative net cash and low operating cash flow coverage of debt. The company has a low dilution risk rating, but its 0.49 price-to-book valuation suggests potential for equity dilution if capital raising is needed. Recent filings show no material dilution events in the past 12 months. Recent events include a 2023 Q2 earnings call where management acknowledged margin compression from raw material price volatility. The company also announced a 5.2 billion JPY investment in a new polyurethane production line in Osaka, with expected capacity expansion by 2025.
Key takeaways
  • Arakawa trades at a 0.49 price-to-book valuation, significantly below the 1.2 median for commodity chemical producers
  • Operating margin of 1.32% is 58% below the 3.1% industry median, indicating competitive challenges
  • 78% revenue concentration in Japan and 54% in construction materials creates geographic and sectoral risk
  • Free cash flow of 1.31 billion JPY is insufficient to cover interest payments on 39.41 billion JPY in long-term debt
  • Earnings estimates suggest a 24% EPS contraction, with operating income projected to fall 22% year-over-year
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$80.24B
Gross profit$16.49B
Operating income$1.06B
Net income$2.64B
R&D
SG&A
D&A
SBC
Operating cash flow$5.12B
CapEx-$4.52B
Free cash flow$1.31B
Total assets$122.30B
Total liabilities$63.82B
Total equity$58.47B
Cash & equivalents$9.43B
Long-term debt$39.41B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$82.14B$1.71B$2.20B$1.47B
FY-1$80.24B$1.06B$2.64B$1.31B
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$126.06B$62.36B$10.60B
FY-1$122.30B$58.47B$9.43B
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0$4.17B-$3.79B$1.47B
FY-1$5.12B-$4.52B$1.31B
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$20.76B$340.0M$870.0M$668.0M
FQ-1$21.01B$440.0M$607.0M$498.0M
FQ-2
FQ-3
FQ-4
FQ-5$20.88B$700.0M$634.0M$621.0M
FQ-6$20.07B-$308.0M-$165.0M-$403.0M
FQ-7$19.26B$622.0M$1.80B$1.51B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$126.06B$62.36B$10.60B
FQ-1$126.62B$59.25B$9.40B
FQ-2
FQ-3
FQ-4
FQ-5$125.27B$57.33B$9.90B
FQ-6$122.24B$58.57B$11.43B
FQ-7$123.93B$58.43B$9.82B
PeriodOCFCapExFCFSBC
FQ0$4.17B-$3.79B$668.0M
FQ-1-$106.0M-$2.49B$498.0M
FQ-2
FQ-3
FQ-4
FQ-5$2.02B-$2.45B$621.0M
FQ-6$3.40B-$1.86B-$403.0M
FQ-7-$464.0M-$695.0M$1.51B
Valuation
Market price$1430.00
Market cap$28.37B
Enterprise value$58.35B
P/E10.7
Reported non-GAAP P/E
EV/Revenue0.7
EV/Op income55.2
EV/OCF11.4
P/B0.5
P/Tangible book0.5
Tangible book$58.47B
Net cash-$29.98B
Current ratio1.7
Debt/Equity0.7
ROA2.2%
ROE4.5%
Cash conversion1.9%
CapEx/Revenue-5.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4968Activity
Op margin1.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin20.6%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity67.0%59.0% medp25 54.9% · p75 72.9%above median
Observations
IR observations
Mean EPS estimate90.70 JPY
Last actual EPS133.31 JPY
Mean revenue estimate84,100,000,000 JPY
Last actual revenue80,236,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-15 00:56 UTC#5e118530
Market quoteclose JPY 1430.00 · shares 0.02B diluted
no public URL
2026-05-15 00:56 UTC#01a53643
Source: analysis-pipeline (hybrid)Generated: 2026-05-15 00:58 UTCJob: b4e0067b